IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Lonza Adds High-Potency Capacity

9:56 AM MDT | June 20, 2007 | Chemical Week Editorial Staff

Lonza says it will build a plant at Visp, Switzerland to produce high-potency active pharmaceutical ingredients at large scale. The facility, which is due to cost SF80 million ($64 million), is scheduled to open in mid-2008. “The project provides Lonza with a unique competitive advantage by being the sole custom manufacturer capable of handling large-scale manufacturing in this arena,” Lonza...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa